AKT1 and prostate cancer: Interestingly, PDK1 RNAi-mediated knockdown does not impair Pten-deleted prostate cancer growth in mice, possibly reflecting mTORC2-mediated activation of AKT, and/or compensatory augmentation of the MAPK cascade [136].